Virginia Tech
    • Log in
    View Item 
    •   VTechWorks Home
    • ETDs: Virginia Tech Electronic Theses and Dissertations
    • Doctoral Dissertations
    • View Item
    •   VTechWorks Home
    • ETDs: Virginia Tech Electronic Theses and Dissertations
    • Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Syntheses and Bioactivities of Targeted and Conformationally Restrained Taxol Analogs

    Thumbnail
    View/Open
    thesis.pdf (43.39Kb)
    Downloads: 188
    maintext-1.pdf (858.9Kb)
    Downloads: 104
    APPENDIX1.pdf (897.2Kb)
    Downloads: 73
    Date
    2004-05-10
    Author
    Liu, Changhui
    Metadata
    Show full item record
    Abstract
    Taxol (1) was first isolated from the bark of the Pacific yew about 35 years ago by Drs. Wall and Wani. Although its development as an anticancer agent was delayed by numerous reasons, including its scarcity and insolubility, the discovery of its tubulin-assembly activity and other factors motivated oncologists to overcome these problems. It has since become one of the most important current drugs for the treatment of several cancers, including breast and ovarian cancers. Like almost all anticancer drugs taxol does have some toxic side effects and many tumors also show significant resistance to therapy with taxol. Drug targeting studies aimed at improving its selectivity and efficacy is described. Two targeting methods, the estrogen receptor (ER) directed targeting and colloidal gold (cAu)directed targeting, were used in our research. In this dissertation, a series of estradiol-taxol conjugates (ETCs) were synthesized. They were active in four cytotoxicity assays and tubulin polymerization assay, but less active than taxol. One of them showed the desired selectivity for ER positive cancer cells. Recently, several studies have attempted to elucidate the bioactive binding conformation of taxol on microtubules. Three models have been proposed for this conformation. The T-taxol conformation was proposed by Dr. Snyder based on electron crystallographic density and molecular modeling. In this dessertation, a series of cyclopropyl-containing taxol analogs and macrocyclic taxol lactones were synthesized. The bioassay results showed they are less active than taxol. The molecular modeling studies suggested that the cyclopropyl-containing taxol analogs could not adopt the T-taxol conformation, which would result in the loss of bioactivities. It is an indirect evidence to support T-taxol conformation. As for macrocyclic taxol lactones, it is proposed that they would have a close contact between the ester moiety on the C-3' phenyl ring and Phe272 of the β-tubulin protein when they adopt T-taxol conformation. It will push the macrocyclics out of the binding pocket and lead to the lost of bioactivities.
    URI
    http://hdl.handle.net/10919/11186
    Collections
    • Doctoral Dissertations [14863]

    Related items

    Showing items related by title, author, creator and subject.

    • Thumbnail

      Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol 

      Chemistry; Center for Drug Discovery; Virginia Polytechnic Institute and State University; Kingston, David G. I.; Molinero, Anthony A.; Gunatilaka, A. Leslie (United States Patent and Trademark Office, 1995-11-28)
      The natural product cephalomannine can be converted to the important anticancer natural product taxol by a simple process involving the steps of dihydroxylation to give cephalomannine-diols, diol cleavage, benzoylation at ...
    • Thumbnail

      Rearranged taxol compounds and method of using in testing of in vivo activity 

      Virginia Tech Intellectual Properties, Inc.; Kingston, David G. I.; Samaranayake, Gamini S. (United States Patent and Trademark Office, 1993-03-16)
      In a preferred embodiment, taxol is treated with mesyl chloride to prepare a taxol derivative with a contracted A-ring, which has comparable activity to taxol in a tubulin depolymerization assay, and which shows cytotoxicity ...
    • Thumbnail

      Rearranged taxol compounds and method of using in testing of in vivo activity 

      Virginia Tech Intellectual Properties, Inc.; Kingston, David G. I.; Samaranayake, Gamini S. (United States Patent and Trademark Office, 1994-03-22)
      In a preferred embodiment, taxol is treated with mesyl chloride to prepare a taxol derivative with a contracted A-ring, which has comparable activity to taxol in a tubulin depolymerization assay, and which shows cytotoxicity ...

    If you believe that any material in VTechWorks should be removed, please see our policy and procedure for Requesting that Material be Amended or Removed. All takedown requests will be promptly acknowledged and investigated.

    Virginia Tech | University Libraries | Contact Us
     

     

    VTechWorks

    AboutPoliciesHelp

    Browse

    All of VTechWorksCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Log inRegister

    Statistics

    View Usage Statistics

    If you believe that any material in VTechWorks should be removed, please see our policy and procedure for Requesting that Material be Amended or Removed. All takedown requests will be promptly acknowledged and investigated.

    Virginia Tech | University Libraries | Contact Us